Cochrane · intervention · CD005517

Materials for retrograde filling in root canal therapy

Li, H, Guo, Z, Li, C, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Oral HealthEndodontics and dental trauma3 versionsAMSTAR 2: not assessed
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
16
current version
GRADE rated
7
No studies
6
Included studies
8
as reported
No studies 6 · 37.5%Ungraded 3 · 18.8%Very low 7 · 43.8%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationParticipants for whom orthograde root canal filling or retreatment was not possible and where periapical surgery was used to save the tooth; no age or gender limitationsPatients needing retrograde filling (1399 participants, 1471 teeth; over 17 years of age; studies published 1995 to 2019); five European, one American, two Asian studies
InterventionRetrograde obturation with any materialMineral trioxide aggregate (MTA); Super ethoxybenzoic acid (Super-EBA); Dentine-bonded resin composite; Glass ionomer cement
ComparisonRetrograde obturation with any material other than that used in the intervention groupIntermediate restorative material (IRM); Super ethoxybenzoic acid (Super-EBA); Glass ionomer cement; Amalgam; Root repair material (RRM)
OutcomesSuccess rate (clinical or radiological methods; minimum 12 months follow-up); Adverse eventsSuccess rate (n=8 studies; 1-, 2-, 4- and 5-year follow-up); Adverse events (n=0, not assessed)
Study designsRandomised controlled trials (RCTs), including cluster, split-mouth and cross-over RCTsRandomised controlled trials (n=8)
TimingMinimum follow-up 12 months1-year follow-up (n=8); 2-year (n=1); 4-year (n=1); 5-year (n=1)

Search date: 2021-04. Databases: Cochrane Oral Health's Trials Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE Ovid; Embase Ovid; LILACS BIREME Virtual Health Library; ClinicalTrials.gov; WHO International Clinical Trials Registry Platform; Chinese BioMedical Literature Database; VIP; China National…

Questions and results

Show all 3 versions

Mineral trioxide aggregate (MTA) vs Intermediate restorative material (IRM)

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
3 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies
Success rate at 1 year
1 year
RR 1.09 [0.97, 1.22]
806 per 1000 vs 879 per 1000
2 studiesVery low
Downgraded: risk of bias, imprecision
Success rate at 2 years
2 years
RR 1.05 [0.92, 1.20]1 studyUngraded

Mineral trioxide aggregate (MTA) vs Super ethoxybenzoic acid (Super-EBA)

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
3 questions
OutcomeEffectEvidenceStatus / GRADE
Success rate at 4 years
4 years
RR 1.02 [0.93, 1.12]1 studyUngraded
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies
Success rate at 1 year
1 year
RR 1.03 [0.96, 1.10]
931 per 1000 vs 959 per 1000
1 studyVery low
Downgraded: risk of bias, imprecision

Super ethoxybenzoic acid (Super-EBA) vs Intermediate restorative material (IRM)

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
2 questions
OutcomeEffectEvidenceStatus / GRADE
Success rate at 1 year
1 year
RR 0.90 [0.80, 1.01]
906 per 1000 vs 815 per 1000
1 studyVery low
Downgraded: risk of bias, imprecision
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies

Dentine-bonded resin composite vs Glass ionomer cement

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
3 questions
OutcomeEffectEvidenceStatus / GRADE
Success rate at 1 year (root as unit, per-protocol analysis)
1 year · Root as unit of analysis (radiological), per-protocol (PP)
RR 1.59 [1.20, 2.09]
519 per 1000 vs 825 per 1000
1 studyVery low
Downgraded: risk of bias, imprecision
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies
Success rate at 1 year (tooth/participant as unit, per-protocol analysis)
1 year · Tooth as unit of analysis, per-protocol (PP)
RR 2.39 [1.60, 3.59]
306 per 1000 vs 731 per 1000
1 studyVery low
Downgraded: risk of bias, imprecision

Glass ionomer cement vs Amalgam

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
3 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies
Success rate at 5 years
5 years
RR 1.00 [0.84, 1.20]1 studyUngraded
Success rate at 1 year
1 year
RR 0.98 [0.86, 1.12]
904 per 1000 vs 886 per 1000
1 studyVery low
Downgraded: risk of bias, imprecision

Mineral trioxide aggregate (MTA) vs Root repair material (RRM)

Population: Patients needing retrograde filling in root canal therapy (orthograde root canal filling or retreatment not possible; periapical surgery used to save the tooth); no age or gender limitations
2 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Adverse events: outcome was not assessed by the included studies0 studiesNo studies
Success rate at 1 year
1 year
RR 1.00 [0.94, 1.07]
933 per 1000 vs 896 per 1000
2 studiesVery low
Downgraded: risk of bias, imprecision